ComGenex Forms Protein Expression Company
By Biotechdaily staff writers
Posted on 06 Aug 2002
The formation of a new molecular biology and recombinant protein expression services company has been announced by ComGenex, Inc. (Budapest, Hungary), a leading European provider of integrated drug discovery chemistry. The new company is called RecomGenex (also in Budapest).Posted on 06 Aug 2002
The new firm will use proprietary technologies to provide a range of services, including cloning, expression, and purification of proteins through mutant protein design, and high throughput protein renaturation. RecomGenex will offer clients molecular biology services, technology access, and collaborative development. Proprietary technologies include XpressXpert for recombinant purification and ImprovEnz technology to generate custom protein mutants on order. RecomGenex has pioneered a protein renaturation process that increases the speed and yield of protein production.
"Now that the industry works on the sequences to express, we are able to contribute with experience and systems to achieve a functional product,” said Geza Ambrus-Aikelin, CEO of RecomGenex. "For the future, we expect our renaturation technology to bring a high-yielding, cost-effective platform for traditionally difficult sequence expression.”
Related Links:
ComGenex
RecomGenex
Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Automatic Hematology Analyzer
DH-800 Series
